Home / Recalls / Medical Devices
Remel Inc recalls Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum, Ref R30164201 ZH01. Product Usage: Suitable for the use in
Recalled January 3, 2018 · FDA recall Z-0290-2018 · Remel
Hazard
The serum may fail to agglutinate within the specified minimum reaction time. · FDA Class II
Units
237 units (single bottles)
Sold at
US Nationwide Distribution
Description
The serum may fail to agglutinate within the specified minimum reaction time.
Product
Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum, Ref R30164201 ZH01. Product Usage: Suitable for the use in slide agglutination tests to identify Shigella cultures presumptively for epidemiological and diagnostic purposes.
Manufacturer(s)
Remel Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →